Valneva SE American Depositary Shares
VALNStock
$5.08−18.46%52W
Market Cap$472.66M
P/E—
Div yield—
Beta1.94
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-57.04%
Price vs S&P 500 (4W)-4.50%
VGM Score48.75
Market Capitalization$472.66M
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.08
4.08
4.08
4.08
Industry Peers — Biological Products(180)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
VALNValneva SE American Depositary Shares | C | C | D | $5.08 |
| AMGNAmgen Inc | C | C | C | $371.58 |
| GILDGilead Sciences Inc | C | B | C | $136.30 |
| ARGXargenx SE American Depositary Shares | D | A | B | $857.97 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $179.18 |
| BIIBBiogen Inc. Common Stock | B | D | B | $208.92 |
| BNTXBioNTech SE American Depositary Share | C | C | C | $91.56 |
| MRNAModerna, Inc. Common Stock | D | B | B | $63.15 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $171.55 |
| EXELExelixis Inc | C | B | B | $55.68 |
| TECHBio-Techne Corp. | D | C | B | $71.77 |
About
Valneva SE is a vaccine company with marketed products for travelers, including IXIARO, DUKORAL, and IXCHIQ. The company generates revenue primarily from vaccine sales while maintaining development programs for new vaccine candidates and COVID-19 vaccine initiatives. Additional revenue streams include technology licensing and manufacturing services.